Hypoxic pulmonary vasoconstriction (HPV) - basic mechanisms

N. Weissmann (Giessen, Germany)

Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease
Number: 9

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Weissmann (Giessen, Germany). Hypoxic pulmonary vasoconstriction (HPV) - basic mechanisms. Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Hypoxic pulmonary vasoconstriction (HPV) shows regional variation in hypoxia response
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002

Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms
Source: Eur Respir J 2008; 32: 1639-1651
Year: 2008

Hypoxic pulmonary vasoconstriction: clinical implications
Source: Eur Respir J 2016; 47: 31-34
Year: 2016

Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017
Year: 2017

Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009

Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006

Effects of hypobaric hypoxia on circulating microRNA expression and hypoxic pulmonary vasoconstriction
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016

Pulmonary hypertension: the science behind the disease spectrum
Source: Eur Respir Rev 2012; 21: 19-26
Year: 2012

Role of tadalafil in patients with hypoxia / lung disease induced (group 3) pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms
Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018
Year: 2018

Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

Hypoxic vasoconstriction of partial muscular intra-acinar pulmonary arteries in the mouse
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006

Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension
Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Year: 2007

RASSF1A regulates ROS-HIF axis in hypoxia driven pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016

Hypoxic challenge testing (HCT) in COPD and pulmonary hypertension (PH)
Source: Eur Respir J 2004; 24: Suppl. 48, 326s
Year: 2004

Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Tetrahydrobiopterin and the regulation of hypoxic pulmonary vasoconstriction
Source: Eur Respir J 2010; 36: 323
Year: 2010

Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007